These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9474253)

  • 1. Marrow transplantation for acute myeloid leukemia.
    Clift RA; Buckner CD
    Cancer Invest; 1998; 16(1):53-61. PubMed ID: 9474253
    [No Abstract]   [Full Text] [Related]  

  • 2. [Further developments in the treatment of acute myeloid leukemia with autologous bone marrow transplantation].
    Löwenberg B
    Ned Tijdschr Geneeskd; 1987 Feb; 131(6):230-2. PubMed ID: 3550483
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of immunotherapy in bone marrow transplantation for acute myeloid leukemia.
    Prentice HG; Macdonald ID; Hamon MD
    Prog Clin Biol Res; 1994; 389():239-43. PubMed ID: 7700907
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of relapse following blood stem cell transplantation for acute myeloid leukemia in first remission.
    Reiffers J
    Bone Marrow Transplant; 1996 May; 17(5):899-901. PubMed ID: 8733721
    [No Abstract]   [Full Text] [Related]  

  • 6. [Possibilities and problems of bone marrow transplantation in the therapy of acute leukemias (author' transl)].
    Kolb HJ
    Klin Padiatr; 1981 May; 193(3):284-91. PubMed ID: 7021990
    [No Abstract]   [Full Text] [Related]  

  • 7. Allogeneic versus autologous marrow transplantation for patients with acute myeloid leukemia in first marrow remission. An update of the Genoa experience with 159 patients.
    Carella AM; Frassoni F; Damasio E; Santini G; Bacigalupo A; Marmont AM; Vitale V
    Leukemia; 1992 Nov; 6 Suppl 4():78-81. PubMed ID: 1434841
    [No Abstract]   [Full Text] [Related]  

  • 8. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
    Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
    J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of CBFbeta/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation.
    Elmaagacli AH; Beelen DW; Kroll M; Trzensky S; Stein C; Schaefer UW
    Bone Marrow Transplant; 1998 Jan; 21(2):159-66. PubMed ID: 9489633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of mismatched HLA detected in the peripheral blood of an AML patient who relapsed after haploidentical hematopoietic stem cell transplantation.
    Park BG; Sohn YH; Oh HB; Seo EJ; Jang S; Hong SP
    Ann Lab Med; 2015 Sep; 35(5):551-3. PubMed ID: 26206697
    [No Abstract]   [Full Text] [Related]  

  • 11. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.
    Zittoun RA; Mandelli F; Willemze R; de Witte T; Labar B; Resegotti L; Leoni F; Damasio E; Visani G; Papa G
    N Engl J Med; 1995 Jan; 332(4):217-23. PubMed ID: 7808487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Cahn JY; Labopin M; Sierra J; Blaise D; Reiffers J; Ferrant A; Bergmann L; Visani G; Cornelissen J; De Witte T; Bosi A; Frassoni F; Gorin NC
    Br J Haematol; 2000 Aug; 110(2):308-14. PubMed ID: 10971386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid Leukemia.
    Zahler S; Bhatia M; Ricci A; Roy S; Morris E; Harrison L; van de Ven C; Fabricatore S; Wolownik K; Cooney-Qualter E; Baxter-Lowe LA; Luisi P; Militano O; Kletzel M; Cairo MS
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):698-704. PubMed ID: 26785332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse and survival after transplantation for complex karyotype acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and the University of Texas MD Anderson Cancer Center.
    Ciurea SO; Labopin M; Socie G; Volin L; Passweg J; Chevallier P; Beelen D; Milpied N; Blaise D; Cornelissen JJ; Fegueux N; Polge E; Kongtim P; Rondon G; Esteve J; Mohty M; Savani BN; Champlin RE; Nagler A
    Cancer; 2018 May; 124(10):2134-2141. PubMed ID: 29469961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow transplantation in acute leukemia [proceedings].
    Schaefer UW; Beyer JH; Boecker WR; Bruntsch U; Gallmeier WM; Hilgard P; Hossfeld DK; Nowrousian MR; Ohl S; Schmidt CG; Wetter O; Glaeser L; Scherer E; Schmitt G; Haralambie E; Linzenmeier G; Rosenthal E; Hierholzer E; Kuwert E; Luboldt W; Popovici CG; Gerhard L; Leder LD; Reinhardt V; Stambolis C; Hantschke D; Oginszus HJ
    Pathol Biol (Paris); 1978 Jan; 26(1):47-8. PubMed ID: 358088
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term outcomes of granulocyte colony-stimulating factor-combined conditioning in allogeneic hematopoietic stem cell transplantation from HLA-identical family donors for myeloid malignancies.
    Konuma T; Kato S; Ishii H; Oiwa-Monna M; Asano S; Tojo A; Takahashi S
    Leuk Res; 2015 Jun; 39(6):625-31. PubMed ID: 25888304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone Marrow WT1 Levels in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplasia: Clinically Relevant Time Points and 100 Copies Threshold Value.
    Nomdedéu JF; Esquirol A; Carricondo M; Pratcorona M; Hoyos M; Garrido A; Rubio M; Bussaglia E; García-Cadenas I; Estivill C; Brunet S; Martino R; Sierra J
    Biol Blood Marrow Transplant; 2018 Jan; 24(1):55-63. PubMed ID: 28939453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wilms Tumor 1 Expression and Pre-emptive Immunotherapy in Patients with Acute Myeloid Leukemia Undergoing an Allogeneic Hemopoietic Stem Cell Transplantation.
    Di Grazia C; Pozzi S; Geroldi S; Grasso R; Miglino M; Colombo N; Tedone E; Luchetti S; Lamparelli T; Gualandi F; Ibatici A; Bregante S; Van Lint MT; Raiola AM; Dominietto A; Varaldo R; Galaverna F; Ghiso A; Sica S; Bacigalupo A
    Biol Blood Marrow Transplant; 2016 Jul; 22(7):1242-1246. PubMed ID: 26970379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for autologous stem cell transplantation for patients with acute myelogenous leukemia? A retrospective analysis.
    Novitzky N; Thomas V; du Toit C; McDonald A
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):875-84. PubMed ID: 20870030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of ABO incompatibility on patients' outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMT.
    Canaani J; Savani BN; Labopin M; Huang XJ; Ciceri F; Arcese W; Tischer J; Koc Y; Bruno B; Gülbas Z; Blaise D; Maertens J; Ehninger G; Mohty M; Nagler A
    Haematologica; 2017 Jun; 102(6):1066-1074. PubMed ID: 28255020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.